Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a Rocket Pharmaceuticals gene therapy for Pyruvate Kinase Deficiency has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyruvate Kinase Deficiency

Drugs mentioned

• Rocket PKD Gene Therapy

Snippet

Sponsor: Rocket Pharmaceuticals Inc. | Conditions: Pyruvate Kinase Deficiency | Phase 2 | Status: SUSPENDED